PTGS2 and cancer: Chronic infection with HBV or HCV is the leading cause of liver cancer [1–3], and elevated expression of COX-2 has been described in different liver cirrhosis animal models and liver tissue from cancer patients with chronic HBV or HCV infections [8, 9, 17, 21].